This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Celgene Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Wai Yip Lee
Introduction
Wai Yip Lee is a notable inventor based in Bedminster, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations and compositions. His work has the potential to impact the treatment of various disorders, including cancer and inflammatory diseases.
Latest Patents
Wai Yip Lee holds 1 patent for his invention titled "Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide." This patent encompasses pharmaceutical compositions and single unit dosage forms of the compound, along with methods for treating, managing, or preventing various disorders.
Career Highlights
Throughout his career, Wai Yip Lee has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Amgen Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
Wai Yip Lee has collaborated with talented individuals such as Nathan Boersen and Ho-Wah Hui. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Wai Yip Lee's contributions to the pharmaceutical field through his innovative patents and collaborations highlight his dedication to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile